Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $30.8 Million - $36 Million
-959,392 Reduced 43.05%
1,269,400 $42.1 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $9.99 Million - $11.6 Million
-276,600 Reduced 11.04%
2,228,792 $81.8 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $7.68 Million - $10 Million
-195,100 Reduced 7.22%
2,505,392 $102 Million
Q4 2022

Aug 11, 2023

BUY
$41.75 - $54.5 $8.15 Million - $10.6 Million
195,100 Added 7.79%
2,700,492 $138 Million
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $38.1 Million - $49.7 Million
911,600 Added 50.96%
2,700,492 $0
Q3 2022

Nov 15, 2022

SELL
$43.76 - $53.42 $19.5 Million - $23.8 Million
-446,208 Reduced 19.96%
1,788,892 $78.3 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $18.1 Million - $21.5 Million
389,400 Added 21.1%
2,235,100 $117 Million
Q1 2022

Apr 25, 2022

BUY
$45.75 - $56.69 $27.2 Million - $33.7 Million
594,600 Added 47.53%
1,845,700 $95.6 Million
Q4 2021

Jan 25, 2022

BUY
$41.32 - $61.25 $24 Million - $35.6 Million
581,000 Added 86.7%
1,251,100 $73.9 Million
Q3 2021

Oct 26, 2021

BUY
$39.25 - $50.42 $26.3 Million - $33.8 Million
670,100 New
670,100 $28.8 Million
Q3 2019

Oct 24, 2019

SELL
$32.49 - $42.13 $75.1 Million - $97.4 Million
-2,312,747 Closed
0 $0
Q2 2019

Jul 16, 2019

BUY
$36.98 - $41.52 $2.29 Million - $2.57 Million
61,900 Added 2.75%
2,312,747 $10 Million
Q1 2019

Oct 03, 2019

BUY
$37.5 - $41.2 $84.4 Million - $92.7 Million
2,250,847 New
2,250,847 $95.6 Million
Q1 2019

Apr 08, 2019

SELL
$37.5 - $41.2 $88.4 Million - $97.1 Million
-2,357,201 Closed
0 $0
Q4 2018

Feb 22, 2019

BUY
$38.47 - $43.86 $90.7 Million - $103 Million
2,357,201 New
2,357,201 $103 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Railway Pension Investments LTD Portfolio

Follow Railway Pension Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Railway Pension Investments LTD with notifications on news.